The efficacy and safety of immunotherapy in thymic epithelial tumors: more effective, more risky: a systematic review

BACKGROUND: Thymic epithelial tumors (TETs) are rare malignant neoplasms originating from thymic epithelial cells. The current treatment for localized TETs is surgical removal. However, 20–30% of thymomas and 70–80% of thymic carcinomas are unresectable, recurrent, or metastatic at the time of detec...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Xinyu, Fan, Jiang, Zhu, Liang, Wang, Zhehai, He, Yayi, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411126/
https://www.ncbi.nlm.nih.gov/pubmed/34527346
http://dx.doi.org/10.21037/jtd-21-290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411126/
https://www.ncbi.nlm.nih.gov/pubmed/34527346
http://dx.doi.org/10.21037/jtd-21-290

Ejemplares similares